Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Medical evaluation Blood pressure, heart rate, weight, medical history, current medications
Retatrutide has not received MHRA or EMA marketing authorisation and is only accessible in the UK through regulated clinical trials
Peak side effect intensity usually occurs on day three to five after injection
En Li ChoEAngCZQuekJFuCLimLHengZet al
This makes Retatrutide a focal point for research into active energy expenditure rather than appetite suppression alone
Additional dual and triple agonists targeting GIP, GLP-1, and glucagon receptors are in late-stage development
US$ 21.94
US$ 28.84
US$ 26.80
US$ 22.39
US$ 27.83
